There’s a strong case to be made that the payer and reimbursement landscape for substance use disorder (SUD) treatment providers is the most challenging in all of behavioral health care due to several deeply entrenched and overlapping issues. For starters, SUD treatment has, in the past, been viewed as less legitimate than other forms of medical or psychiatric care. That flawed view has caused some to see SUDs as a “social issue,” rather than a clinical one, contributing to chronic underfunding and limited reimbursement.
Read the full article: Medicaid, Denials and Delays: Top Payer Hurdles for SUD Treatment Providers //
Source: https://bhbusiness.com/2025/05/28/medicaid-denials-and-delays-top-payer-hurdles-for-sud-treatment-providers/